But six years ago his condition worsened and was offered the chance to join the UK-wide FLAIR trial, combining targeted drugs venetoclax and ibrutinib - that block chemical signals telling the ...

But a University of Leeds-led FLAIR trial offered Cathy less invasive treatment options, which she has described as "really smooth sailing". "Thanks to this, my life has remained as normal as it ...